跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-ALENDRONATE alendronate sodium trihydrate (equivalent to 70 mg alendronic acid) tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
APO-ALENDRONATE alendronate sodium trihydrate (equivalent to 70 mg alendronic acid) tablet blister pack
Approved
STANDARD
APO-ALENDRONATE alendronate sodium trihydrate (equivalent to 70 mg alendronic acid) tablet blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f42b50c6cb4ecfd4
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
f42b50c6cb4ecfd4
Product Name
APO-ALENDRONATE alendronate sodium trihydrate (equivalent to 70 mg alendronic acid) tablet blister pack
Artg Id
123863
Artg Name
APO-ALENDRONATE alendronate sodium trihydrate (equivalent to 70 mg alendronic acid) tablet blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2006-08-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/585ff97c48216b150bd30c606862a35e.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/372d29ed49a4811fdfe11ddffb188509.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f42b50c6cb4ecfd4
Type
Standard
Back to TGA Approvals